Status:
COMPLETED
Natural History of Gastroesophageal Reflux (GER) in Children and Adolescents
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
AstraZeneca
Conditions:
Gastroesophageal Reflux
Eligibility:
All Genders
20-50 years
Brief Summary
The goal of this project is to determine the long-term health outcome of children diagnosed with gastroesophageal reflux (GER). We are inviting subjects that were previously followed in the Pediatric ...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Subjects:
- Patients who were evaluated for GERD at the age of 12-17 years, inclusive at Children's Hospital, Boston or Massachusetts General Hospital
- Positive for GERD per biopsies or pH probe results
- Exclusion Criteria for Subjects:
- None
- Inclusion Criteria for Controls:
- No GI diseases prior to age 21 including, but not limited to reflux, inflammatory bowel disease,Hirschsprung's disease
- Date of birth is within 1 year of a subject's date of birth
Exclusion
Key Trial Info
Start Date :
September 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00181805
Start Date
September 1 2004
End Date
December 1 2014
Last Update
December 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital
Boston, Massachusetts, United States, 02114